258 related articles for article (PubMed ID: 7008871)
1. Characterization of hematologic malignancies by flow cytometry.
Barlogie B; Latreille J; Freireich EJ; Fu CT; Mellard D; Meistrich M; Andreeff M
Blood Cells; 1980; 6(4):719-44. PubMed ID: 7008871
[TBL] [Abstract][Full Text] [Related]
2. Double-stranded RNA excess in hematologic diseases: clinical implications.
Musso M; Abbadessa V; Perricone R; Di Miceli F; Quaratino S; Di Caro A; Cajozzo A
Haematologica; 1989; 74(1):5-9. PubMed ID: 2498183
[TBL] [Abstract][Full Text] [Related]
3. Quantitative cytology in leukemia research.
Barlogie B; Maddox AM; Johnston DA; Raber MN; Drewinko B; Keating MJ; Freireich EJ
Blood Cells; 1983; 9(1):35-55. PubMed ID: 6344934
[TBL] [Abstract][Full Text] [Related]
4. The importance of blast cell DNA content for prognosis of childhood acute lymphoblastic leukemia.
Starý J; Hrodek O; Hausner P; Petráková A; Goetz P; Kreuger A
Neoplasma; 1990; 37(3):293-9. PubMed ID: 2370916
[TBL] [Abstract][Full Text] [Related]
5. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
[TBL] [Abstract][Full Text] [Related]
6. Recognition of central nervous system leukemia by flow cytometry.
Redner A; Andreeff M; Miller DR; Steinherz P; Melamed M
Cytometry; 1984 Nov; 5(6):614-8. PubMed ID: 6596184
[TBL] [Abstract][Full Text] [Related]
7. Characterization of proliferative and quiescent leukemic cells by flow cytometry.
Preisler HD; Darzynkiewicw Z
J Med; 1981; 12(6):415-25. PubMed ID: 6948070
[TBL] [Abstract][Full Text] [Related]
8. Cellular DNA of human neoplastic B-cells measured by flow cytometry.
Braylan RC; Benson NA; Nourse VA
Cancer Res; 1984 Nov; 44(11):5010-6. PubMed ID: 6435862
[TBL] [Abstract][Full Text] [Related]
9. DNA, RNA, and protein content in adult acute myeloid leukemia: effects of cytostatic drugs in vivo.
Wolowiec D; Ffrench M; Tigaud JD; Treille-Ritouet D; Archimbaud E; Bryon PA
Leukemia; 1988 Aug; 2(8):534-9. PubMed ID: 3166079
[TBL] [Abstract][Full Text] [Related]
10. Aneuploidy as a marker of minimal residual disease in leukemia.
Walle AJ; Niedermayer W
Cancer Detect Prev; 1985; 8(1-2):303-15. PubMed ID: 4064049
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of flow cytometry.
Raber MN
Oncology (Williston Park); 1988 Mar; 2(3):35-43, 47. PubMed ID: 3079323
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric determination of ploidy and proliferative activity on isolated bone marrow particles and on total bone marrow aspirate.
Ucci G; Mazzini G; Caporali R; Danova M; Montecucco CM; Riccardi A
Basic Appl Histochem; 1987; 31(1):83-90. PubMed ID: 3593175
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias.
Riccardi A; Montecucco CM; Danova M; Ucci G; Mazzini G; Giordano PA; Pasquali F
Basic Appl Histochem; 1986; 30(2):181-92. PubMed ID: 2427061
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the phenotype and cellular DNA content in some leukemias by flow cytometry.
Kusenda J; Glasová M; Babusíková O
Neoplasma; 1995; 42(6):347-52. PubMed ID: 8592578
[TBL] [Abstract][Full Text] [Related]
16. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of DNA aneuploidy as a tumor marker].
Takamoto S
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
[TBL] [Abstract][Full Text] [Related]
18. RNA and DNA content of isolated nuclei from bladder irrigation specimens as measured by flow cytometry.
Staiano-Coico L; Wolf R; Darzynkiewicz Z; Whitmore WF; Melamed MR
Anal Quant Cytol; 1984 Mar; 6(1):24-9. PubMed ID: 6203451
[TBL] [Abstract][Full Text] [Related]
19. Identification of drug-resistant myeloid leukemic cells by measurement of DNA content, nuclear area, and detection of P-glycoprotein.
Emura I; Naito M; Kakihara T; Wakabayashi M; Hayashi N; Chou T
Cancer; 1996 Mar; 77(5):878-87. PubMed ID: 8608478
[TBL] [Abstract][Full Text] [Related]
20. DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography.
Costa A; Mazzini G; Del Bino G; Silvestrini R
Cytometry; 1981 Nov; 2(3):185-8. PubMed ID: 7297353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
